Galecto Inc (GLTO)
0.6179
-0.01
(-1.92%)
USD |
NASDAQ |
May 17, 16:00
0.6179
0.00 (0.00%)
After-Hours: 20:00
Galecto Enterprise Value: -10.33M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | -10.33M |
| May 16, 2024 | -10.09M |
| May 15, 2024 | -10.03M |
| May 14, 2024 | -8.734M |
| May 13, 2024 | -8.732M |
| May 10, 2024 | -8.740M |
| May 09, 2024 | -8.189M |
| May 08, 2024 | -8.056M |
| May 07, 2024 | -7.918M |
| May 06, 2024 | -7.918M |
| May 03, 2024 | -8.189M |
| May 02, 2024 | -7.731M |
| May 01, 2024 | -8.732M |
| April 30, 2024 | -8.856M |
| April 29, 2024 | -8.146M |
| April 26, 2024 | -8.062M |
| April 25, 2024 | -9.035M |
| April 24, 2024 | -8.978M |
| April 23, 2024 | -8.176M |
| April 22, 2024 | -8.707M |
| April 19, 2024 | -8.694M |
| April 18, 2024 | -7.650M |
| April 17, 2024 | -8.886M |
| April 16, 2024 | -8.536M |
| April 15, 2024 | -8.536M |
| Date | Value |
|---|---|
| April 12, 2024 | -8.707M |
| April 11, 2024 | -8.189M |
| April 10, 2024 | -8.734M |
| April 09, 2024 | -7.802M |
| April 08, 2024 | -7.888M |
| April 05, 2024 | -6.565M |
| April 04, 2024 | -7.379M |
| April 03, 2024 | -7.316M |
| April 02, 2024 | -6.430M |
| April 01, 2024 | -6.975M |
| March 28, 2024 | -12.00M |
| March 27, 2024 | -12.00M |
| March 26, 2024 | -12.69M |
| March 25, 2024 | -13.04M |
| March 22, 2024 | -11.90M |
| March 21, 2024 | -12.38M |
| March 20, 2024 | -11.76M |
| March 19, 2024 | -12.55M |
| March 18, 2024 | -12.21M |
| March 15, 2024 | -10.98M |
| March 14, 2024 | -12.09M |
| March 13, 2024 | -12.79M |
| March 12, 2024 | -11.28M |
| March 11, 2024 | -11.74M |
| March 08, 2024 | -9.560M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-62.78M
Minimum
May 24 2022
509.70M
Maximum
Nov 23 2020
16.78M
Average
-13.73M
Median
Nov 09 2021
Enterprise Value Benchmarks
| Novo Nordisk A/S | 590.10B |
| Genmab A/S | 15.08B |
| Ascendis Pharma A/S | 7.294B |
| Evaxion Biotech AS | 22.47M |
| IO Biotech Inc | -27.07M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.477M |
| Total Expenses (Quarterly) | 5.741M |
| EPS Diluted (Quarterly) | -0.20 |
| Earnings Yield | -183.5% |